Literature DB >> 11163576

Automation of laboratory testing for infectious diseases using the polymerase chain reaction-- our past, our present, our future.

D Jungkind1.   

Abstract

While it is an extremely powerful and versatile assay method, polymerase chain reaction (PCR) can be a labor-intensive process. Since the advent of commercial test kits from Roche and the semi-automated microwell Amplicor system, PCR has become an increasingly useful and widespread clinical tool. However, more widespread acceptance of molecular testing will depend upon automation that allows molecular assays to enter the routine clinical laboratory. The forces driving the need for automated PCR are the requirements for diagnosis and treatment of chronic viral diseases, economic pressures to develop more automated and less expensive test procedures similar to those in the clinical chemistry laboratories, and a shortage in many areas of qualified laboratory personnel trained in the types of manual procedures used in past decades. The automated Roche COBAS AMPLICOR system has automated the amplification and detection process. Specimen preparation remains the most labor-intensive part of the PCR testing process, accounting for the majority of the hands-on-time in most of the assays. A new automated specimen preparation system, the COBAS AmpliPrep, was evaluated. The system automatically releases the target nucleic acid, captures the target with specific oligonucleotide probes, which become attached to magnetic beads via a biotin-streptavidin binding reaction. Once attached to the beads, the target is purified and concentrated automatically. Results of 298 qualitative and 57 quantitative samples representing a wide range of virus concentrations analyzed after the COBAS AmpliPrep and manual specimen preparation methods, showed that there was no significant difference in qualitative or quantitative hepatitis C virus (HCV) assay performance, respectively. The AmpliPrep instrument decreased the time required to prepare serum or plasma samples for HCV PCR to under 1 min per sample. This was a decrease of 76% compared to the manual specimen preparation method. Systems that can analyze more samples with higher throughput and that can answer more questions about the nature of the microbes that we can presently only detect and quantitate will be needed in the future.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11163576     DOI: 10.1016/s1386-6532(00)00148-7

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  19 in total

1.  Evaluation of a new automated, standardized generic nucleic acid extraction method (total nucleic acid isolation kit) used in combination with cytomegalovirus DNA quantification by COBAS AMPLICOR CMV MONITOR.

Authors:  Barbara Christine Gärtner; Johannes Michael Fischinger; Anke Litwicki; Klaus Roemer; Nikolaus Mueller-Lantzsch
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Clinical applications of molecular biology for infectious diseases.

Authors:  David J Speers
Journal:  Clin Biochem Rev       Date:  2006-02

3.  Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, Version 1.5, on clinical laboratory operations.

Authors:  Jeffrey J Germer; Jordan L Bendel; Craig A Dolenc; Sarah R Nelson; Amanda L Masters; Tara M Gerads; Jayawant N Mandrekar; P Shawn Mitchell; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

4.  Entirely automated quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma by using the ultrasensitive COBAS AMPLICOR HIV-1 monitor test and RNA purification on the MagNA pure LC instrument.

Authors:  Gabriele Hölzl; Markus Stöcher; Victoria Leb; Herbert Stekel; Jörg Berg
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR.

Authors:  Kurt Beuselinck; Marc van Ranst; J van Eldere
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

6.  Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.

Authors:  Isabelle Desombere; Hans Van Vlierberghe; Sibyl Couvent; Filip Clinckspoor; Geert Leroux-Roels
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

7.  Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay.

Authors:  Christophe Ronsin; Anne Pillet; Corinne Bali; Gérard-Antoine Denoyel
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

8.  Evaluation of automated sample preparation and quantitative PCR LCx assay for determination of human immunodeficiency virus type 1 RNA.

Authors:  Zsofia Muller; Evelyn Stelzl; Michael Bozic; Josef Haas; Egon Marth; Harald H Kessler
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Quantification of parvovirus B19 DNA using COBAS AmpliPrep automated sample preparation and LightCycler real-time PCR.

Authors:  Stefan Schorling; Gunnar Schalasta; Gisela Enders; Michael Zauke
Journal:  J Mol Diagn       Date:  2004-02       Impact factor: 5.568

10.  Rapid quantification of hepatitis B virus DNA by automated sample preparation and real-time PCR.

Authors:  Evelyn Stelzl; Zsofia Muller; Egon Marth; Harald H Kessler
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.